J. Goldman & Co’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 489 |
|
|
2025
Q1 | – | Sell |
-14,456
| Closed | -$582K | – | 492 |
|
|
2024
Q4 | $582K | Buy |
+14,456
| New | +$582K | 0.02% | 259 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 488 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 461 |
|
|
2023
Q4 | – | Sell |
-92,219
| Closed | -$1.02M | – | 354 |
|
|
2023
Q3 | $1.02M | Buy |
+92,219
| New | +$1.02M | 0.04% | 157 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 383 |
|
|
2022
Q4 | – | Sell |
-135,000
| Closed | -$367K | – | 375 |
|
|
2022
Q3 | $367K | Buy |
+135,000
| New | +$367K | 0.02% | 221 |
|
|
2019
Q4 | – | Sell |
-12,857
| Closed | -$88K | – | 259 |
|
|
2019
Q3 | $88K | Buy |
+12,857
| New | +$88K | 0.01% | 156 |
|
|
2018
Q3 | – | Sell |
-82,698
| Closed | -$785K | – | 268 |
|
|
2018
Q2 | $785K | Buy |
+82,698
| New | +$785K | 0.04% | 165 |
|